Efficacies of artemether–lumefantrine, artesunate–amodiaquine, dihydroartemisinin–piperaquine, and artesunate–pyronaridine for the treatment of uncomplicated Plasmodium falciparum malaria in children aged 6 months to 10 years in Uganda: a randomised, open-label, phase 4 clinical trial
Moses R. Kamya, Joaniter I. Nankabirwa, Chris Ebong, Victor Asua, Moses Ν. Kiggundu, Stephen Orena, Martin Okitwi, Stephen Tukwasibwe, Bosco Agaba, Daniel Kyabayinze, Jimmy Opigo, Damian Rutazana, Benjamin Binagwa, Edward Mugwanya, Shakira Babirye, Gloria Sebikaari, Patrick Condo, Grace D. Appiah, Samuel L. Nsobya, Melissa D. Conrad, Philip J. Rosenthal, Leah F. Moriarty, Adoke Yeka
Topics & Concepts
ArtesunateAmodiaquineMedicineArtemetherMalariaArtemether/lumefantrinePlasmodium falciparumLumefantrineDihydroartemisininPiperaquineArtemisininImmunologyMalaria Research and ControlPharmaceutical Quality and CounterfeitingHistorical Medical Research and Treatments